Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agencyโs recent increased flexibilities.
Company (Product Origin): Mead Johnson Nutrition/Reckitt (Singapore)
Product(s): Base powder to manufacture Enfamil Stage 1
Type of Formula: Finished product will be general infant formula
Estimated Quantity: 4.5 million pounds of base powder that will be used to produce about 5.7 million cans (more than 66 million full-size, 8-ounce bottles).
Availability: Base powder will begin shipping in June to a Minnesota facility for conversion to final product that will be made available in the coming weeks. Monthly follow-on shipments will continue through November. The U.S. Department of Health and Human Services is evaluating options for getting the product to the U.S. as quickly as possible.
More Information and Where to Find the Products: The finished product would be used to meet contractual obligations under the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) program.
The FDA is exercising enforcement discretion for the importation of the infant formula products listed above following the review of information provided pertaining to nutritional adequacy and safety, including microbiological testing, labeling, and additional information about facility production and inspection history.
The agency is leveraging a number of flexibilities to bolster the supply of products that serve as the sole source of nutrition for many infants while ensuring the infant formula can be used safely and provides adequate nutrition. The FDA remains in further discussions with manufacturers and suppliers regarding additional supply to ensure thereโs adequate infant formula available wherever and whenever parents and caregivers need it.
The FDA issued guidance on May 16 that outlined a process by which the agency would not object to the importation of certain infant formula products intended for a foreign market or distribution in the U.S. of products manufactured here for export to foreign countries. This guidance also may provide flexibilities to those who manufacture infant formula products domestically and may be able to increase further the quantity of domestically produced product for the U.S. market. The agency has posted a webpage that will be updated with information about additional products headed to the U.S.
Ongoing FDA Steps to Increase Availability of Safe, Nutritious Infant Formula
The agencyโs around-the-clock work as part of the all-of-government efforts has already begun to improve supply and availability. The agency expects that the measures and steps it is taking, and the resumption of production at the Abbott Nutritionโs Sturgis, Mich., facility, will mean more and more supply is on the way or on store shelves moving forward.
The FDA continues to advise against making infant formulas at home or diluting formula. Parents and caregivers are encouraged to work with their childโs health care provider for recommendations on changing feeding practices, if needed. The U.S. Department of Health and Human Services also has additional information available at HHS.gov/formula, including information to help families find infant formula.
The agency also monitors online marketplaces for fraudulent products and works with major online retailers to remove violative and harmful products offered for sale on their sites. Additionally, since many of these fraudulent products originate overseas, the agency targets and examines these products at ports of entry. The FDA also monitors and follows up on various external signals such as consumer complaints about potential counterfeit and fraudulent products.
The FDA will continue to dedicate all available resources to help ensure that safe and nutritious infant formula products remain available for use in the U.S. and will keep the public informed of progress updates.
ย
Infant Formula Update
Related Information
- Infant Formula Information and Ongoing FDA Efforts to Increase Supply
- Enforcement Discretion to Manufacturers to Increase Infant Formula Supplies
- HHS.gov/formula
- HHS.gov/news
- FDA Investigation of Cronobacter Infections: Powdered Infant Formula (February 2022)
- Powdered Infant Formula Recall: What to Know
- CDC Information on Cronobacter Infection and Infants
- Duncan NRI at Texas Children’s Hospital Accelerates Neurological Research and Therapies with Historic $10M Gift from The Blue Bird Circle
HOUSTONย /PRNewswire/ — The Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital today announced it received aย $10 millionย donation from The Blue Bird Circle. The Duncan NRI is a multidisciplinary group of 30+ physicians and scientists from Baylor College of Medicine working together to accelerate life-saving research and to develop effective therapies for theโฆ Read more: Duncan NRI at Texas Children’s Hospital Accelerates Neurological Research and Therapies with Historic $10M Gift from The Blue Bird Circle - La Importancia de las Vacunas Regulares para la Salud Cardรญaca
(Family Features) Si bien la mayorรญa de los padres son buenos para hacer un seguimiento de las vacunas que sus hijos necesitan para mantenerse saludables, muchos adultos no se dan cuenta de que las vacunas tambiรฉn son importantes para mantenerse saludables para el corazรณn. Los adultos, especialmente aquellos con antecedentes de enfermedad cardรญaca o ataqueโฆ Read more: La Importancia de las Vacunas Regulares para la Salud Cardรญaca - As health problems stack up, so do serious financial woes, study shows
Being in โpoor healthโ is far more than just a saying, according to a new University of Michigan study. - FOUNDATION FOR SARCOIDOSIS RESEARCH LAUNCHES ITS FIRST-EVER CLINICAL TRIAL EQUITY INITIATIVE FOR BLACK AND AFRICAN AMERICANS
The Ignore No More: ACTe Now! Campaign to address vast health disparities by seeking more inclusive approach to recruiting Black American patients for clinical trials and research CHICAGO — The Foundation for Sarcoidosis Research (FSR) is proud to announce the launch of theย Ignore No More: ACTe Now!ย (Advance Clinical Trials for Equity in Sarcoidosis) campaign. Theโฆ Read more: FOUNDATION FOR SARCOIDOSIS RESEARCH LAUNCHES ITS FIRST-EVER CLINICAL TRIAL EQUITY INITIATIVE FOR BLACK AND AFRICAN AMERICANS 
Relationships: Can Someone Fear Human Contact If They Had An Intrusive Caregiver?One thing that someone could often struggle with is feeling alone and isolated from others. During this time, they could be desperate for human contact and hope that they will soon spend time with another or a few others. However, if this was to take place, it doesn’t mean that their whole being would showโฆ Read more: <br>Relationships: Can Someone Fear Human Contact If They Had An Intrusive Caregiver?
https://tnc.network/lifestyle/
